| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.861 | 0.003 | 0.909 | Antiamyloidogenic | 0.909 0.002 DBMET01681 0.887 0.003 DBMET01143 | DBMET01681 | |
| 0.852 | 0.001 | 0.98 | Topoisomerase I inhibitor | 0.763 0.002 DBMET01681 0.98 0.001 DBMET01143 | DBMET01143 | |
| 0.833 | 0.003 | 0.935 | DNA intercalator | 0.79 0.003 DBMET01681 0.935 0.002 DBMET01143 | DBMET01143 | |
| 0.651 | 0.001 | 0.81 | Antineoplastic alkaloid | 0.446 0.001 DBMET01681 0.81 0 DBMET01143 | DBMET01143 | |
| 0.64 | 0.004 | 0.756 | Topoisomerase II inhibitor | 0.605 0.005 DBMET01681 0.756 0.003 DBMET01143 | DBMET01143 | |
| 0.638 | 0.005 | 0.676 | Hypoxia-inducible factor 1 alpha inhibitor | 0.353 0.044 DBMET01681 0.676 0.005 DBMET01143 | DBMET01143 | |
| 0.647 | 0.04 | 0.783 | Apoptosis agonist | 0.607 0.048 DBMET01681 0.783 0.019 DBMET01143 | DBMET01143 | |
| 0.501 | 0.014 | 0.644 | DNA damaging | 0.596 0.008 DBMET01681 0.644 0.006 DBMET01143 | DBMET01143 | |
| 0.444 | 0.003 | 0.629 | Beta amyloid protein antagonist | 0.441 0.003 DBMET01681 0.629 0.002 DBMET01143 | DBMET01143 | |
| 0.225 | 0.011 | 0.256 | Breast cancer-resistant protein inhibitor | 0.143 0.026 DBMET01681 0.256 0.009 DBMET01143 | DBMET01143 | |
| 0.223 | 0.037 | 0.223 | Cholinergic | 0.15 0.076 DBMET01681 | ||
| 0.282 | 0.105 | 0.501 | Transcription factor NF kappa B inhibitor | 0.255 0.124 DBMET01681 0.501 0.044 DBMET01143 | DBMET01143 | |
| 0.235 | 0.063 | 0.327 | Amyloid beta aggregation inhibitor | 0.327 0.04 DBMET01681 0.233 0.063 DBMET01143 | DBMET01681 | |
| 0.212 | 0.05 | 0.212 | Amyloid beta precursor protein antagonist | 0.142 0.11 DBMET01681 | ||
| 0.166 | 0.036 | 0.428 | Cyclooxygenase 3 inhibitor | 0.171 0.032 DBMET01681 0.428 0.004 DBMET01143 | DBMET01143 | |
| 0.143 | 0.023 | 0.143 | Acetylcholine M3 receptor agonist | |||
| 0.232 | 0.129 | 0.403 | Caspase 3 stimulant | 0.202 0.166 DBMET01681 0.403 0.044 DBMET01143 | DBMET01143 | |
| 0.115 | 0.014 | 0.172 | Bombesin 1 receptor agonist | 0.098 0.018 DBMET01681 0.172 0.006 DBMET01143 | DBMET01143 | |
| 0.245 | 0.152 | 0.311 | Immunosuppressant | 0.264 0.138 DBMET01681 0.311 0.108 DBMET01143 | DBMET01143 | |
| 0.167 | 0.093 | 0.174 | P-glycoprotein inhibitor | 0.161 0.101 DBMET01681 0.174 0.085 DBMET01143 | DBMET01143 | |
| 0.13 | 0.059 | 0.2 | Alkylator | 0.198 0.027 DBMET01681 0.2 0.026 DBMET01143 | DBMET01143 | |
| 0.082 | 0.013 | 0.289 | Topoisomerase II beta inhibitor | 0.289 0.003 DBMET01143 | DBMET01143 | |
| 0.128 | 0.06 | 0.171 | Cell adhesion inhibitor | 0.171 0.035 DBMET01681 | DBMET01681 | |
| 0.091 | 0.045 | 0.241 | Topoisomerase II alpha inhibitor | 0.118 0.031 DBMET01681 0.241 0.011 DBMET01143 | DBMET01143 | |
| 0.098 | 0.064 | 0.12 | Butyrylcholinesterase inhibitor | 0.12 0.047 DBMET01681 | DBMET01681 | |
| 0.182 | 0.151 | 0.318 | DNA synthesis inhibitor | 0.175 0.161 DBMET01681 0.318 0.038 DBMET01143 | DBMET01143 | |
| 0.06 | 0.029 | 0.06 | Acetylcholine M2 receptor agonist | |||
| 0.04 | 0.011 | 0.066 | Estrogen-related receptor beta antagonist | 0.031 0.025 DBMET01681 0.066 0.004 DBMET01143 | DBMET01143 | |
| 0.04 | 0.035 | 0.04 | DNA gyrase subunit A inhibitor | 0.039 0.037 DBMET01143 | ||
| 0.028 | 0.027 | 0.028 | Potassium channel (Inward rectifier) 1 blocker | |||
| 0.101 | 0.104 | 0.12 | Acetylcholinesterase inhibitor | 0.12 0.078 DBMET01681 | DBMET01681 | |
| 0.062 | 0.092 | 0.09 | Cell adhesion molecule inhibitor | 0.09 0.042 DBMET01681 | DBMET01681 | |
| 0.108 | 0.138 | 0.299 | Heat shock protein 90 antagonist | 0.299 0.01 DBMET01143 | DBMET01143 | |
| 0.085 | 0.137 | 0.134 | Estrogen antagonist | 0.134 0.034 DBMET01143 | DBMET01143 | |
| 0.107 | 0.183 | 0.159 | Antimitotic | 0.159 0.113 DBMET01143 | DBMET01143 | |
| 0.06 | 0.154 | 0.114 | Estrogen receptor beta antagonist | 0.114 0.04 DBMET01143 | DBMET01143 | |
| 0.104 | 0.2 | 0.162 | Hypolipemic | 0.162 0.125 DBMET01681 | DBMET01681 | |
| 0.106 | 0.21 | 0.167 | Lipocortins synthesis antagonist | 0.146 0.111 DBMET01681 0.167 0.084 DBMET01143 | DBMET01143 | |
| 0.011 | 0.122 | 0.045 | Estrogen agonist | 0.045 0.039 DBMET01143 | DBMET01143 | |
| 0.021 | 0.218 | 0.06 | Androgen agonist | 0.06 0.042 DBMET01143 | DBMET01143 | |
| 0.125 | 0.376 | 0.213 | Interleukin 2 agonist | 0.213 0.168 DBMET01681 | DBMET01681 | |
| 0.054 | 0.317 | 0.211 | Heat shock protein 90 alpha antagonist | 0.211 0.043 DBMET01143 | DBMET01143 | |
| 0.061 | 0.336 | 0.14 | Interleukin 6 antagonist | 0.14 0.105 DBMET01143 | DBMET01143 | |
| 0.033 | 0.328 | 0.072 | Estrogen receptor alpha antagonist | 0.072 0.063 DBMET01143 | DBMET01143 | |
| 0.048 | 0.355 | 0.091 | Interleukin 12 antagonist | 0.091 0.07 DBMET01143 | DBMET01143 | |
| 0.095 | 0.405 | 0.227 | Sodium/bile acid cotransporter inhibitor | 0.227 0.154 DBMET01681 | DBMET01681 | |
| 0.136 | 0.448 | 0.346 | Caspase 9 stimulant | 0.346 0.149 DBMET01143 | DBMET01143 | |
| 0.062 | 0.411 | 0.241 | Neurotrophic factor enhancer | 0.241 0.044 DBMET01143 | DBMET01143 | |
| 0.045 | 0.401 | 0.227 | Prostaglandin dehydrogenase inhibitor | 0.227 0.14 DBMET01143 | DBMET01143 | |
| 0.02 | 0.696 | 0.134 | GABA C receptor rho-2 antagonist | 0.134 0.099 DBMET01143 | DBMET01143 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |